Your browser doesn't support javascript.
loading
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Vaklavas, Christos; Roberts, Brian S; Varley, Katherine E; Lin, Nancy U; Liu, Minetta C; Rugo, Hope S; Puhalla, Shannon; Nanda, Rita; Storniolo, Anna Maria; Carey, Lisa A; Saleh, Mansoor N; Li, Yufeng; Delossantos, Jennifer F; Grizzle, William E; LoBuglio, Albert F; Myers, Richard M; Forero-Torres, Andres.
Afiliação
  • Vaklavas C; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Roberts BS; Present Address: Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.
  • Varley KE; HudsonAlpha, Institute for Biotechnology, Huntsville, AL, USA.
  • Lin NU; HudsonAlpha, Institute for Biotechnology, Huntsville, AL, USA.
  • Liu MC; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rugo HS; Lombardi Cancer Center, Georgetown University Hospital, Washington, DC, USA.
  • Puhalla S; University of California, San Francisco, USA.
  • Nanda R; Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • Storniolo AM; University of Pittsburgh Medical Center, Magee Women's Cancer Program, Pittsburgh, PA, USA.
  • Carey LA; University of Chicago, Chicago, IL, USA.
  • Saleh MN; Melvin and Bren Simon Cancer Center at Indiana University, Indianapolis, IN, USA.
  • Li Y; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Delossantos JF; Georgia Cancer Specialists PC, Atlanta, GA, USA.
  • Grizzle WE; University of Alabama at Birmingham, Birmingham, AL, USA.
  • LoBuglio AF; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Myers RM; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Forero-Torres A; University of Alabama at Birmingham, Birmingham, AL, USA.
Breast Cancer Res ; 22(1): 22, 2020 02 18.
Article em En | MEDLINE | ID: mdl-32070401

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Progesterona / Receptores de Estrogênio / Neoplasias Hormônio-Dependentes Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Progesterona / Receptores de Estrogênio / Neoplasias Hormônio-Dependentes Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article